Creating a platform to improve cancer cell analysis using advanced algorithms and antibody techniques
A data-driven bioinformatics platform for the design and analysis of multiplexed antibody-based cytometry experiments in cancer research
This study is working on a new tool to help scientists better understand cancer cells by making it easier to analyze different types of cells in tumors, which could lead to more accurate cancer tests and better treatment options for patients.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10887641 on NIH RePORTER |
What this research studies
This research focuses on enhancing the analysis of cancer cells by developing a bioinformatics platform that automates the design and analysis of multiplexed antibody-based cytometry experiments. By utilizing existing single-cell transcriptomic data, the project aims to improve the identification and characterization of various cell populations within tumors. This approach seeks to reduce the manual effort involved in data annotation, thereby increasing the accuracy and reproducibility of results. Patients may benefit from more precise cancer diagnostics and treatment strategies based on improved understanding of tumor ecosystems.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with various types of cancer who are undergoing treatment or evaluation.
Not a fit: Patients with non-cancerous conditions or those not undergoing any form of cellular analysis may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate cancer diagnostics and personalized treatment options for patients.
How similar studies have performed: Other research has shown success in using bioinformatics to enhance cancer diagnostics, indicating that this approach has potential for significant advancements.
Where this research is happening
Philadelphia, United States
- University of Pennsylvania — Philadelphia, United States (Active)
Researchers
- Principal investigator: Gonzalez Camara, Pablo — University of Pennsylvania
- Study coordinator: Gonzalez Camara, Pablo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.